Drreddys Laboratories reported 13.75B in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Ani Pharmaceuticals ANIP:US $ 18.82M 1.23M
Aphria Inc APH:CN C$ 74.04M 19.84M
Bayer BAYN:GR 3.75B 226M
Canopy Growth Corp WEED:CN C$ 111.05M 38.77M
Catalent CTLT:US $ 184.1M 11.4M
Cipla CIPLA:IN 8.87B 725.7M
Corcept Therapeutics CORT:US $ 30.03M 520K
Drreddys Laboratories RDY:US 13.75B 816M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
GlaxoSmithKline GSK:LN 2.5B 183M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Hikma Pharmaceutical HIK:LN 232M 3M
Horizon Pharma HZNP:US 355.2M 23.21M
JAZZ PHA JAZZ:US 429.03M 168.52M
Lannett LCI:US $ 21.58M 3.94M
Novartis NOVN:VX 3.71B 190M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Phibro Animal Health PAHC:US $ 50.67M 1.64M
Prestige Brands PBH:US $ 61.91M 1.67M
Richter Gedeon RICHT:HB 35.1B 1.39B
Sun Pharmaceuticals SUNP:IN 17.59B 812.9M
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M
Teva Pharmaceutical TEVA:IT 832M 16M